Hims & Hers Health (HIMS) has formed a cup-with-handle base that offers a buy point at 60.55. The stock had surged 126% year-to-date, as of Monday, according to IBD MarketSurge. Hims stock is Tuesday's selection for IBD 50 Stocks To Watch. This is an early-stage base that can net higher gains that later ones do. Hims & Hers Health makes… Related news Breakout Stocks Watch: What Looms For October? 10/01/2025As October gets underway with market indexes near record highs, these stocks to watch highlight rules ...

Industry Overview - The health and fitness industry has transitioned from a niche market to a global growth engine, driven by a cultural emphasis on healthier living and proactive self-care [2] - Consumers are increasingly seeking balanced nutrition, structured fitness routines, and comprehensive wellness solutions, leading to a growing demand for gyms, supplements, and tailored programs [2] - The global health and wellness market is projected to reach $11 trillion by 2034, with a compound annual growth rate (CAGR) of 5.4% from 2025 [4] Role of Technology - Technology giants like Apple and Amazon are significantly influencing the health and fitness landscape through innovations such as the Apple Watch, Fitness+ platform, and One Medical [3] - These technologies are merging fitness, healthcare, and daily life, enhancing consumer engagement and driving industry growth [3] Key Companies United Natural Foods (UNFI) - UNFI offers a diverse portfolio of nearly 230,000 products focused on health and wellness, including natural, organic, and personal care items [7] - The company has invested in organic certification and sustainability, with 33 U.S. distribution centers registered as Organic Handlers [8] - UNFI's digital platforms support emerging wellness brands, and its foundation promotes regenerative agriculture and nutrition education [9] American Well Corporation (Amwell) - Amwell is a digital healthcare platform that provides telehealth services and integrates various healthcare offerings through its Converge platform [10] - The company has evolved from traditional telehealth to a holistic digital care model, focusing on chronic disease management and wellness initiatives [11] - Amwell has improved its financial position through cost reductions and innovation, aiming to be a leader in digital wellness [12] SunOpta - SunOpta specializes in plant-based and fruit-based products, catering to the demand for minimally processed foods [13] - The company has shifted towards higher-margin categories and emphasizes sustainability in its sourcing and production practices [15] - Recent innovations include expanding its plant-based and organic product portfolio to align with consumer health values [15] Peloton Interactive - Peloton has developed a connected fitness platform that combines advanced equipment with immersive digital content and community engagement [16] - The company has transitioned from a hardware-centric model to a balanced approach of product sales and recurring subscription revenues [17] - Peloton continues to innovate by expanding its content library and exploring international markets, positioning itself for long-term growth in the fitness sector [19]

Core Insights - Over 90% of U.S. adults are classified as metabolically unhealthy, indicating a growing crisis of metabolic dysfunction [1] - Metabolic dysfunction is associated with various challenges, including being overweight and difficulties in maintaining energy and long-term health [1] - Medifast, a health and wellness company with over 40 years of experience, is focusing on addressing this issue through its science-backed, coach-guided lifestyle system [1]

Core Viewpoint - Aja Health and Wellness Inc. is working towards filing its annual audited financial statements for the year ending December 31, 2024, and its unaudited interim financial statements for the three months ended March 31, 2025, after facing delays due to a reverse takeover transaction [2][3]. Group 1: Financial Filings - The Alberta Securities Commission issued a Failure-to-File Cease Trade Order (FFCTO) on August 1, 2025, due to the company's inability to meet filing deadlines for the Annual and Interim Filings [2]. - The delay in filing the Annual Filings is attributed to the need for a valuation of the purchase price allocation related to the reverse takeover transaction that closed on September 17, 2024 [3]. - The company expects to finalize the Annual Filings by September 30, 2025, pending the completion of the valuation [3][4]. Group 2: Future Expectations - Aja anticipates that the FFCTO will remain in effect until the Annual and Interim Filings are submitted [4]. - The company is actively working to complete the Interim Filings and aims to file them by September 30, 2025 [4].

Core Insights - Limitless X Holdings, Inc. has launched a new Investor Relations website to enhance transparency and communication with investors [1][2] - The company operates through various subsidiaries in Health and Wellness, Film and Television Production, Sports Media, Digital Assets, and Lifestyle Real Estate, positioning itself for multi-vertical growth [1][2][4] Investor Relations Website Features - The new Investor Relations site provides centralized access to financials, shareholder letters, governance, and updates across all operating divisions [1][2] - It aims to empower investors by consolidating shareholder communications, financial reporting, and strategic insights [2][6] Company Overview - Limitless X Holdings is focused on creating a high-growth, value-driven ecosystem that promotes health, wellness, entertainment, and lifestyle innovation [4] - The company is expanding its Direct-to-Consumer eCommerce platform and developing wellness-centered communities and premium lifestyle destinations [4] Strategic Goals - Limitless X is positioned for aggressive international expansion and exceptional customer engagement through a strengthening global distribution network and strategic partnerships [4] - The company emphasizes long-term value creation and transparency in its operations [2][4]

Core Insights - Hims & Hers Health, Inc. (HIMS) is a consumer-first health and wellness platform that connects patients with licensed healthcare professionals, focusing on personalized and accessible care [1][2] - The company reported over 2.4 million subscribers in Q2 2025, with 1.5 million receiving personalized treatment, showcasing its commitment to holistic health solutions [2][7] - HIMS is expanding into new health domains such as hormonal health and longevity through acquisitions, aiming to promote preventive and personalized wellness [3][7] Company Performance - Hims & Hers shares have increased by 75.1% year to date, significantly outperforming the industry growth of 21.6% [6] - The Zacks Consensus Estimate for HIMS' 2025 earnings per share indicates a 122.2% improvement from 2024 [8] Financial Metrics - HIMS' forward 12-month price-to-sales (P/S) ratio is 3.6X, lower than the industry's average of 5.7X but higher than its three-year median of 2.4X [10] - The consensus estimates for HIMS' earnings per share for the current quarter, next quarter, current year, and next year are 0.09, 0.12, 0.60, and 0.80 respectively, with significant year-over-year growth expected [11]

Core Insights - WW International (formerly WeightWatchers) reported its first quarter earnings post-bankruptcy, surpassing both earnings and revenue estimates [1] - The company achieved $65 million in adjusted EBITDA, reflecting nearly 30% growth compared to the previous year's results [1] Financial Performance - The adjusted EBITDA of $65 million indicates a strong recovery and operational efficiency post-bankruptcy [1] - The growth rate of almost 30% year-over-year demonstrates the company's ability to rebound and improve its financial standing [1]

Core Insights - Investview, Inc. reported its financial results for Q2 2025, highlighting operational progress and strategic initiatives across its diversified business segments [1] Financial Performance - Gross Revenue decreased by 24.7% to $10.4 million for Q2 2025 compared to $13.8 million in Q2 2024 [5] - Net Revenue decreased by 23.5% to $10.0 million for Q2 2025 compared to $13.1 million in Q2 2024 [5] - Net loss from operations was $0.02 million for Q2 2025, a decline from a net income of $0.5 million in Q2 2024 [5] - For the first half of 2025, Gross Revenue decreased by 30.5% to $21.1 million compared to $30.3 million in the same period of 2024 [5] - Net cash used in operating activities was $3.7 million for the first half of 2025, down from net cash provided of $10.3 million in the same period of 2024 [5] Cash Flow and Balance Sheet - Cash and cash equivalents decreased by 28.1% to $16.2 million as of June 30, 2025, from $22.5 million at the end of 2024 [4] - Total assets decreased by 6.4% to $29.5 million, while total liabilities decreased by 15.6% to $12.0 million [12] - The current ratio improved to 2.42, up by 8.7% from December 31, 2024 [12] Business Segment Highlights Financial Education and Technology - iGenius reported net revenue of $7.8 million for Q2 2025, down from $12.0 million in Q2 2024, attributed to shifts in consumer spending and macroeconomic challenges [7] - The company is expanding its product offerings and sales network to counteract negative trends [7][8] Blockchain Technology and Crypto Mining - SAFETek generated $0.8 million in net revenue for Q2 2025, down from $1.1 million in Q2 2024, impacted by Bitcoin halving and increased mining difficulty [9] - Despite challenges, SAFETek produced 8.21 Bitcoin during the quarter, benefiting from reduced power costs [10][31] - The segment has over 1,500 mining machines ready for deployment, positioning for future growth [14] Health, Beauty, and Wellness Products - Renu Laboratories reported $1.4 million in net revenue for Q2 2025, a 259.4% increase from Q1 2025, following strategic investments post-acquisition [16][32] - The myLife Wellness division is set for a commercial launch in Q4 2025, aiming to expand its product portfolio [19][20] Financial Services Initiatives - The Opencash app, a mobile-first trading platform, is on track for launch in Q4 2025, offering low-cost, commission-free trading [22][33] - The platform aims to enhance market reach through partnerships with iGenius, targeting direct-to-consumer markets [27][28] Share Repurchase Program - The company launched a stock repurchase program in March 2025, repurchasing over 6.1 million shares at an average price of $0.0147 per share, representing a 24.8% discount to market value [6][35]

Financial Performance - Q2 2025 net sales reached $1.3 billion, aligning closely with the midpoint of the company's guidance range[12] - Adjusted EBITDA for Q2 2025 was $174 million, surpassing the company's guidance[12] - The company repaid $55 million in debt, including $50 million of 2025 Notes[12] - The company's gross profit margin increased by 10 bps year-over-year to 78%[31] - Adjusted diluted EPS was $0.59, which includes an $0.11 year-over-year foreign exchange headwind[31] Regional Performance - New distributor growth occurred in 4 out of 5 regions year-over-year, with Latin America leading at a 16% increase[12] - Worldwide net sales decreased by 1.7% year-over-year, but remained flat on a constant currency basis[34] - Latin America experienced a 9% increase in local currency net sales[34] Product Launches and Initiatives - The company launched the Herbalife Flex45 Challenge globally[12] - The company expanded the Diamond Development Mastermind Program to South and Central America[12] - The company launched MultiBurn, a multifunctional weight-loss supplement[12] - The company unveiled the beta version of the Pro2col digital platform[12] Future Outlook - The company projects net sales to increase between 0.5% and 4.5% year-over-year for Q3 2025[42] - The company anticipates adjusted EBITDA between $150 million and $160 million for Q3 2025[42] - The company expects full-year 2025 net sales to range from a decrease of 1% to an increase of 3% year-over-year[42]

Core Insights - Medifast, Inc. reported second-quarter 2025 results with both net sales and earnings exceeding Zacks Consensus Estimates, despite year-over-year declines in both metrics [1][11] - The company is focusing on personalized support through its OPTAVIA program to meet growing consumer demand for long-term health and wellness solutions [1] Financial Performance - Quarterly earnings were reported at 22 cents per share, benefiting from an investment in LifeMD, with adjusted earnings at 4 cents per share, surpassing break-even estimates [3][11] - Net revenues fell to $105.6 million, a decline of 37.4% year over year, attributed to a decrease in active earning OPTAVIA coaches, although it exceeded the Zacks Consensus Estimate of $95 million [4][11] - The average revenue per active earning OPTAVIA Coach decreased by 6.9% year over year to $4,630, influenced by challenges in client acquisition and the rise of GLP-1 medications for weight loss [4][11] Coach and Customer Base - The number of active earning OPTAVIA Coaches decreased by 32.7% year over year, dropping to 22,800 from 33,900 [5] - The company is prioritizing the revitalization of its coach and customer base by introducing enhanced tools, data-driven support, and new products [2] Margin and Cost Analysis - Gross profit was reported at $76.6 million, down 37.9% year over year, with a gross margin of 72.6%, reflecting a decrease of 60 basis points [6] - Selling, general and administrative expenses (SG&A) fell by 40.8% year over year to $77.7 million, primarily due to a reduction in OPTAVIA coach compensation [7] Operational Loss and Financial Health - The loss from operations improved by 86.5% to $1.1 million, representing 1% of revenues compared to 4.7% in the previous year [8] - As of June 30, 2025, the company had cash, cash equivalents, and investment securities totaling $162.7 million, with no debt and total shareholders' equity of $216 million [9] Future Outlook - For the third quarter of 2025, Medifast expects revenues between $70 million and $90 million, with potential losses ranging from 60 cents to break-even [12]